Eli Lilly has announced a new weight-loss shot that the company claims is more powerful than existing GLP-1s. The drug has shown significant weight loss results in trials, with reports suggesting it has helped patients lose around 28-30% of their body weight. The extent of its effectiveness compared to other obesity treatments and surgeries is still being reported, with some outlets suggesting it may outperform existing options.